Covered recipient · General Payments record
MICHAEL DUFFEY
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,533.82
- Reported across 178 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $348.67 | 28 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $198.83 | 22 |
| E.R. Squibb & Sons, L.L.C. | $75.29 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.57 | 1 |
| Incyte Corporation | $25.29 | 1 |
| Dermavant Sciences, Inc. | $14.41 | 1 |
| Arcutis Biotherapeutics, Inc. | $13.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.21 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664076 | CMS |
| ABBVIE INC. | $8.93 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664078 | CMS |
| ABBVIE INC. | $6.10 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664080 | CMS |
| ABBVIE INC. | $10.32 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664082 | CMS |
| ABBVIE INC. | $10.55 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664084 | CMS |
| ABBVIE INC. | $9.43 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664086 | CMS |
| ABBVIE INC. | $8.45 | 03/26/2024 | Education | Undisputed | 01/23/2026 | 1104195350 | CMS |
| ABBVIE INC. | $9.53 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664088 | CMS |
| ABBVIE INC. | $8.06 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664090 | CMS |
| ABBVIE INC. | $3.72 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664092 | CMS |
| ABBVIE INC. | $8.50 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664094 | CMS |
| ABBVIE INC. | $14.54 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664096 | CMS |
| ABBVIE INC. | $29.26 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664098 | CMS |
| ABBVIE INC. | $9.68 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664100 | CMS |
| ABBVIE INC. | $1.49 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664102 | CMS |
| ABBVIE INC. | $10.06 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664104 | CMS |
| ABBVIE INC. | $4.40 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664106 | CMS |
| ABBVIE INC. | $4.46 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664108 | CMS |
| ABBVIE INC. | $5.74 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664110 | CMS |
| ABBVIE INC. | $17.26 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664112 | CMS |
| ABBVIE INC. | $5.62 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664114 | CMS |
| ABBVIE INC. | $6.52 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664116 | CMS |
| Arcutis Biotherapeutics, Inc. | $13.73 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121064371 | CMS |
| Dermavant Sciences, Inc. | $14.41 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127863190 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.60 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101831497 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.25 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101831512 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.44 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101831530 | CMS |
| Incyte Corporation | $25.29 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141205979 | CMS |
| Novartis Pharmaceuticals Corporation | $29.57 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086868639 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.